Vaccines

Hundreds of millions of people worldwide, chronically suffer from Hepatitis each year. With a person dying every 30 seconds from a hepatitis related illness – even in the current COVID-19 pandemic – one cannot neglect its severity.¹ The major challenge we face in eradicating this disease today is to preventing the fatality of chronic infection and avoiding acute infection in at-risk populations.²

Every day, we encounter billions of germs, but they’re not all bad. Intangible but effective, Immunity ensures resistance against harmful microorganisms from entering the body and causing disease.

COVAXIN™ (BBV152) showed long-term antibody and T-cell memory responses (3-months after vaccination) in phase 1 volunteers, and tolerable safety outcomes with enhanced humoral & cell-mediated immune responses in the Phase 2 study.

COVAXIN™ (BBV152) demonstrated acceptable safety profile and high immune response, which induced T-cell responses in Phase 1 study.

Vaccines have proven to be a boon to the mankind and can be regarded as potential weapons against infectious diseases.  An Ideal Vaccine, like discussed in our previous blog, is the requisite for a disease-free world.

COVAXIN™ (BBV152) Shows Demonstration of Protective Efficacy and Immunogenicity in Non-Human Primates

Vaccines are biological products that protect people against many diseases that can be very dangerous and fatal, by producing immunity to a specific disease.^[1] They reduce risks of getting a disease by working with body’s natural defenses to build protection.^[2] Till date, several vaccines